Evidence map›Paper›PMID 34936987›Full record

ArticleAnatomy & cell biology2021

The role of hesperidin in ameliorating retinal changes in rats with experimentally induced type 1 diabetes mellitus and the active role of vascular endothelial growth factor and glial fibrillary acidic protein.

Azza Saad Shehata, Dalia Abduelmoein Mohamed, Sherein Mahmoud Hagras, Shimaa Mohsen El-Beah, Heba Mohamed Elnegris

Open access · hybridAbstract read
In one paragraph

Article in Anatomy & cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Astrocytic responses to high glucose impair barrier formation in cerebral microvessel endothelial cells.American journal of physiology. Regulatory, integrative and comparative physiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Azza Saad ShehataDepartment of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.ORCID https://orcid.org/0000-0002-5095-107X
Dalia Abduelmoein MohamedDepartment of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.ORCID https://orcid.org/0000-0003-0471-4687
Sherein Mahmoud HagrasOphthalmology Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt.ORCID https://orcid.org/0000-0001-6560-3839
Shimaa Mohsen El-BeahDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.ORCID https://orcid.org/0000-0003-1398-0194
Heba Mohamed ElnegrisDepartment of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.ORCID https://orcid.org/0000-0002-6265-6959
Zagazig University · EGMansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with type 1 diabetes mellitus (T

Indexed as

Glial fibrillary acidic proteinHesperidinRetinaType I diabetes mellitusVascular endothelial growth factor

Identifiers

PMID34936987
PMCPMC8693142
OpenAlexW4200429006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.